Treatment of protozoal infection

Details Treatment of protozoal infection Treatment of protozoal infection

1992-10-23

1994-04-05

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 11, A61K 3700

Patent

active

053004914

ABSTRACT:
Protozoal infection of human beings or animals is treated with a divalent metal salt of bacitracin. Some infectious agents sensitive to such treatment include human pathogens such as Entamoeba histolytica, Trichomonas vaginilis, Gtardia lamblia, Cryptosporidium parvum, and animal pathogens such as Tritrichomonas foetus and Tritrichomonas gallinae.

REFERENCES:
patent: 2594374 (1950-06-01), Welch
patent: 2676134 (1955-09-01), Felsenfeld
patent: 2803584 (1957-08-01), Hodge et al.
patent: 2903357 (1959-09-01), Zorn
patent: 2985533 (1961-05-01), Zorn
patent: 3021217 (1962-02-01), Zorn
patent: 4693992 (1987-09-01), Young
patent: 5061689 (1991-10-01), Alvarez
Adler et al. J. Bact. 83, 1315-1317 (1962).
Kadison et al., The Journal of Pediatrics 38, pp. 576-589 (1951).
Gillin et al., Journal of Antimicrobial Chemotherapy 8, 305-316 (1981).
Sharma et al., Archives of Opthalmology 108, 5, p. 625 (May 1990).
Lindquist et al., Archives of Opthalmology 106, 1, 73-77 (Jan. 1988).
Most et al., The American Journal of Tropical Medicine 30, 493-497 (1950).

Affiliated with

Also associated with

Rating

Treatment of protozoal infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of protozoal infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of protozoal infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-511071